Edward B Garon Selected Research

Edward B Garon Research Topics

Disease

103	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 07/2010
66	Neoplasms (Cancer) 03/2024 - 08/2007
24	Disease Progression 11/2023 - 02/2012
21	Lung Neoplasms (Lung Cancer) 10/2023 - 05/2011
6	Fatigue 01/2021 - 08/2014
5	Melanoma (Melanoma, Malignant) 01/2024 - 01/2017
5	Neoplasm Metastasis (Metastasis) 10/2021 - 12/2012
4	Pneumonia (Pneumonitis) 03/2023 - 01/2018
4	Circulating Neoplastic Cells 01/2020 - 06/2012
4	Hypertension (High Blood Pressure) 01/2020 - 08/2014
3	Dyspnea (Shortness of Breath) 12/2023 - 10/2020
3	Cough 01/2023 - 01/2020
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 06/2012
3	Febrile Neutropenia 01/2020 - 08/2014
3	Adenocarcinoma 01/2018 - 10/2012
2	Diarrhea 12/2023 - 01/2017
2	Pain (Aches) 12/2023 - 10/2020
2	Pneumothorax 11/2021 - 12/2019
2	Brain Neoplasms (Brain Tumor) 08/2021 - 10/2020
2	Carcinogenesis 04/2021 - 01/2021
2	Neutropenia 01/2020 - 08/2014
2	Thrombocytopenia (Thrombopenia) 11/2019 - 06/2012
2	Breast Neoplasms (Breast Cancer) 01/2015 - 07/2010
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2023
1	Hemoptysis 12/2023
1	Constipation 12/2023
1	Vomiting 12/2023
1	Nausea 12/2023
1	Thrombosis (Thrombus) 10/2023
1	Mesothelioma 01/2022
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	Residual Neoplasm 01/2022
1	Hypoxia (Hypoxemia) 01/2021

Drug/Important Bio-Agent (IBA)

32	pembrolizumabIBA 01/2024 - 04/2015
22	Biomarkers (Surrogate Marker)IBA 02/2023 - 02/2012
20	RamucirumabIBA 01/2023 - 11/2012
18	PlatinumIBA 10/2023 - 11/2012
16	Immune Checkpoint InhibitorsIBA 01/2024 - 04/2015
16	Docetaxel (Taxotere)FDA Link 01/2023 - 11/2012
13	Pemetrexed (MTA)FDA Link 10/2023 - 10/2013
13	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2023 - 11/2011
12	ErbB Receptors (EGF Receptor)IBA 01/2022 - 11/2011
10	B7-H1 AntigenIBA 01/2023 - 05/2018
8	durvalumabIBA 03/2024 - 01/2020
8	Tyrosine Kinase InhibitorsIBA 10/2021 - 01/2013
8	LigandsIBA 08/2021 - 01/2018
7	Carboplatin (JM8)FDA LinkGeneric 10/2023 - 10/2013
7	NivolumabIBA 01/2023 - 10/2015
6	tremelimumabIBA 03/2024 - 01/2020
6	Bevacizumab (Avastin)FDA Link 10/2017 - 11/2012
5	Monoclonal AntibodiesIBA 03/2020 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 04/2021 - 02/2012
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 12/2013
3	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 10/2013
3	osimertinibIBA 03/2023 - 01/2021
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 12/2019
3	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2020
3	Immunoglobulins (Immunoglobulin)IBA 03/2020 - 10/2017
3	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 01/2019 - 06/2013
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2013 - 07/2010
2	InterleukinsIBA 10/2023 - 03/2020
2	canakinumab FDA Link 10/2023 - 03/2020
2	capmatinibIBA 01/2023 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2022
2	Circulating Tumor DNAIBA 12/2022 - 01/2020
2	VaccinesIBA 12/2022 - 11/2020
2	Aromatase (CYP19)IBA 04/2021 - 12/2012
2	Peptides (Polypeptides)IBA 12/2020 - 06/2012
2	dacomitinibIBA 05/2019 - 01/2017
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2019 - 06/2013
2	Anaplastic Lymphoma KinaseIBA 01/2018 - 03/2016
2	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2018 - 03/2013
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018 - 10/2017
2	Fulvestrant (Faslodex)FDA Link 01/2018 - 03/2013
2	CrizotinibIBA 01/2018 - 02/2015
2	Epidermal Growth Factor (EGF)IBA 12/2017 - 01/2015
2	Estrogen ReceptorsIBA 01/2015 - 03/2013
1	Immunoconjugates (Immunoconjugate)IBA 10/2023
1	Surface Antigens (Surface Antigen)IBA 10/2023
1	SteroidsIBA 03/2023
1	Temozolomide (Temodar)FDA LinkGeneric 01/2023
1	cyclopropapyrroloindoleIBA 01/2023
1	mocetinostatIBA 01/2023
1	Histone Deacetylase InhibitorsIBA 01/2023
1	lenvatinibIBA 01/2023
1	ChemokinesIBA 01/2023
1	atezolizumabIBA 01/2023
1	DV281IBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2020
1	Glutamic Acid (Glutamate)FDA Link 12/2020

Therapy/Procedure

43	Therapeutics 03/2024 - 08/2007
30	Drug Therapy (Chemotherapy) 03/2024 - 09/2012
17	Immunotherapy 01/2023 - 10/2015
6	Radiotherapy 01/2024 - 10/2013
2	Retreatment 11/2020 - 10/2020
1	Aftercare (After-Treatment) 11/2023
1	Chemoradiotherapy 02/2023
1	Neoadjuvant Therapy 01/2023
1	Injections 11/2021
1	Chest Tubes (Chest Tube) 11/2021